Just released from FDAnews — Investigations Operations Manual 2014 — the FDA’s own internal guidance on how to inspect a drug or device company. Know what the investigators look for — before they even get there.
Websites, medical meetings, television talk shows, trade shows . . . wherever your products are being mentioned, chances are good the FDA is watching and looking for violations of the rules covering promotions. And with the agency cranking out three more social media guidances in 2014, you can expect even more challenges in the way the FDA evaluates promotions in the months ahead. Now’s the time to take stock of your promotional review practices and see if they’re really covering all the places they need to – even those you might least expect. And what you can do about it if they’re not.
The Chinese Department of Health has issued a field safety notice for Terumo Cardiovascular Systems’ Terumo CDI Blood Parameter Monitoring System 500 due to a faulty contact between the power cables and the sharp edge of the chassis that can potentially damage the cables’ insulation, resulting in an electrical short.